Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression

被引:17
|
作者
Selhorst, Philippe [1 ]
Combrinck, Carina [1 ]
Ndabambi, Nonkululeko [1 ]
Ismail, Sherazaan D. [1 ]
Abrahams, Melissa-Rose [1 ]
Lacerda, Miguel [2 ]
Samsunder, Natasha [3 ]
Garrett, Nigel [3 ]
Karim, Quarraisha Abdool [3 ,4 ]
Karim, Salim S. Abdool [3 ,4 ]
Williamson, Carolyn [1 ,3 ,5 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Dept Pathol, Cape Town, South Africa
[2] Univ Cape Town, Fac Sci, Dept Stat Sci, Cape Town, South Africa
[3] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa
[4] Columbia Univ, Dept Epidemiol, New York, NY USA
[5] Natl Hlth Lab Serv, Johannesburg, South Africa
关键词
HIV; replication capacity; acute infection; disease progression; tenofovir; CAPRISA; 004; infectivity; isolates; heterosexual transmission; pathogenesis; VIRAL-LOAD; TYPE-1; REPLICATION; TENOFOVIR GEL; MAJOR DETERMINANT; SEX-DIFFERENCES; GAG-PROTEASE; TRANSMISSION; IMPACT; FITNESS; NEF;
D O I
10.1128/JVI.01806-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral genotype has been shown to play an important role in HIV pathogenesis following transmission. However, the viral phenotypic properties that contribute to disease progression remain unclear. Most studies have been limited to the evaluation of Gag function in the context of a recombinant virus backbone. Using this approach, important biological information may be lost, making the evaluation of viruses obtained during acute infection, representing the transmitted virus, a more biologically relevant model. Here, we evaluate the roles of viral infectivity and the replication capacity of viruses from acute infection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide trial. We show that viral replication capacity, but not viral infectivity, correlates with the set point viral load (Spearman r = 0.346; P = 0.045) and that replication capacity (hazard ratio [HR] = 4.52; P = 0.01) can predict CD4 decline independently of the viral load (HR = 2.9; P = 0.004) or protective HLA alleles (HR = 0.61; P = 0.36). We further demonstrate that Gag-Pro is not the main driver of this association, suggesting that additional properties of the transmitted virus play a role in disease progression. Finally, we find that although viruses from the tenofovir arm were 2-fold less infectious, they replicated at rates similar to those of viruses from the placebo arm. This indicates that the use of tenofovir gel did not select for viral variants with higher replication capacity. Overall, this study supports a strong influence of the replication capacity in acute infection on disease progression, potentially driven by interaction of multiple genes rather than a dominant role of the major structural gene gag. IMPORTANCE HIV disease progression is known to differ between individuals, and defining which fraction of this variation can be attributed to the virus is important both clinically and epidemiologically. In this study, we show that the replication capacity of viruses isolated during acute infection predicts subsequent disease progression and drives CD4 decline independently of the viral load. This provides further support for the hypothesis that the replication capacity of the transmitted virus determines the initial damage to the immune system, setting the pace for later disease progression. However, we did not find evidence that the major structural gene gag drives this correlation, highlighting the importance of other genes in determining disease progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [11] HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection
    Margalith, M
    Levy, E
    Rinaldo, CR
    Detels, R
    Phair, J
    Kaslow, R
    Saah, AJ
    Sarov, B
    JOURNAL OF HUMAN VIROLOGY, 2001, 4 (05) : 269 - 277
  • [12] Reduced Replication Capacity of NL4-3 Recombinant Viruses Encoding Reverse Transcriptase-Integrase Sequences From HIV-1 Elite Controllers
    Brumme, Zabrina L.
    Li, Chun
    Miura, Toshiyuki
    Sela, Jennifer
    Rosato, Pamela C.
    Brumme, Chanson J.
    Markle, Tristan J.
    Martin, Eric
    Block, Brian L.
    Trocha, Alicja
    Kadie, Carl M.
    Allen, Todd M.
    Pereyra, Florencia
    Heckerman, David
    Walker, Bruce D.
    Brockman, Mark A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (02) : 100 - 108
  • [13] HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection
    de Azevedo, Suwellen S. D.
    Delatorre, Edson
    Cortes, Fernanda H.
    Hoagland, Brenda
    Grinsztejn, Beatriz
    Veloso, Valdilea G.
    Souza, Thiago Moreno L.
    Morgado, Mariza G.
    Bello, Gonzalo
    AIDS, 2019, 33 (03) : 399 - 410
  • [14] Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection
    Esbjornsson, Joakim
    Mansson, Fredrik
    Kvist, Anders
    Isberg, Per-Erik
    Nowroozalizadeh, Salma
    Biague, Antonio J.
    da Silva, Zacarias J.
    Jansson, Marianne
    Fenyo, Eva Maria
    Norrgren, Hans
    Medstrand, Patrik
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03) : 224 - 232
  • [15] Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection
    Ojwach, Doty B. A.
    MacMillan, Daniel
    Reddy, Tarylee
    Novitsky, Vladimir
    Brumme, Zabrina L.
    Brockman, Mark A.
    Ndung'u, Thumbi
    Mann, Jaclyn K.
    JOURNAL OF VIROLOGY, 2018, 92 (19)
  • [16] Innate immunity in acute HIV-1 infection
    Borrow, Persephone
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (05) : 353 - 363
  • [17] Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers
    Miura, Toshiyuki
    Brumme, Zabrina L.
    Brockman, Mark A.
    Rosato, Pamela
    Sela, Jennifer
    Brumme, Chanson J.
    Pereyra, Florencia
    Kaufmann, Daniel E.
    Trocha, Alicja
    Block, Brian L.
    Daar, Eric S.
    Connick, Elizabeth
    Jessen, Heiko
    Kelleher, Anthony D.
    Rosenberg, Eric
    Markowitz, Martin
    Schafer, Kim
    Vaida, Florin
    Iwamoto, Aikichi
    Little, Susan
    Walker, Bruce D.
    JOURNAL OF VIROLOGY, 2010, 84 (15) : 7581 - 7591
  • [18] CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression
    Raymond, Stephanie
    Delobel, Pierre
    Mavigner, Maud
    Cazabat, Michelle
    Encinas, Stephanie
    Souyris, Corinne
    Bruel, Patrick
    Sandres-Saune, Karine
    Marchou, Bruno
    Massip, Patrice
    Izopet, Jacques
    AIDS, 2010, 24 (15) : 2305 - 2312
  • [19] Immunogenetic basis of HIV-1 infection., transmission and disease progression
    Singh, Paras
    Kaur, Gurvinder
    Sharma, Gaurav
    Mehra, Narinder K.
    VACCINE, 2008, 26 (24) : 2966 - 2980
  • [20] MICRONUTRIENTS AND HIV-1 DISEASE PROGRESSION
    BAUM, MK
    SHORPOSNER, G
    LU, Y
    ROSNER, B
    SAUBERLICH, HE
    FLETCHER, MA
    SZAPOCZNIK, J
    EISDORFER, C
    BURING, JE
    HENNEKENS, CH
    AIDS, 1995, 9 (09) : 1051 - 1056